Market Performance - The Hang Seng Index closed down by 0.21% and the Hang Seng Tech Index fell by 0.67% [1] - Oriental Selection experienced a significant drop, closing down over 20% after reaching a peak increase of 23% during the day [1] Biopharmaceutical Sector - Biopharmaceutical stocks continued to decline, with Gilead Sciences-B dropping over 15%, Peijia Medical-B down over 8%, and Hengrui Medicine falling over 5% [1] Other Notable Stocks - Zhihu saw a notable increase, rising over 23% [1]

Company Performance - On August 19, Oriental Selection's stock price experienced significant volatility, initially surging over 20% to reach a new high, followed by a sharp decline of more than 15% within a short period [3] - If investors had purchased shares at the peak, they would have faced a loss exceeding 30% just twenty minutes later [3] - Following the departure of Dong Yuhui, Oriental Selection's stock price increased by 229%, contradicting initial concerns about the company's viability without him [3] Market Reaction - The market reacted negatively to the news of Dong Yuhui's departure, with Oriental Selection's stock dropping over 23% on the first trading day after the announcement, resulting in a market value loss of 3 billion HKD [3] - The stock hit a low of 8.92 HKD during this period [3] Industry Insights - Analysts from Zheshang Securities noted that the rise of brands like Pang Donglai and Sam's Club reflects consumer recognition of high-quality retail brands, similar to Oriental Selection's approach of focusing on high-quality, cost-effective products to meet health needs [4]

Group 1 - The stock price of Dongfang Zhenxuan experienced significant volatility, initially rising over 20% to reach a new high, followed by a sharp decline of more than 15% within a short period [2][4] - After the departure of Dong Yuhui, the stock price of Dongfang Zhenxuan surged by 229%, contradicting initial concerns about the company's viability without him [4][5] - The market reaction to Dong Yuhui's departure included a notable drop of over 23% in Dongfang Zhenxuan's stock price on the first trading day following the announcement, resulting in a market value loss of 3 billion HKD [5] Group 2 - The A-share market showed signs of fluctuation, with the three major indices experiencing slight adjustments, closing with minor declines [7] - A total of 2,984 stocks rose, while 2,255 stocks fell, indicating a mixed market sentiment [8] - The total trading volume reached approximately 26,406.80 billion, reflecting active trading despite the market's overall downturn [9]

Market Performance - The Hang Seng Index closed down by 0.21% [1] - The Hang Seng Tech Index fell by 0.67% [1] Company Movements - Oriental Selection experienced a significant drop, closing down over 20% after a peak increase of 23% during the day [1] - Biopharmaceutical stocks continued to decline, with Genscript Biotech Corporation (歌礼制药-B) dropping over 15%, Peijia Medical (派格生物医药-B) down over 8%, and Hengrui Medicine (恒瑞医药) falling over 5% [1] - Zhihu saw a notable increase, rising over 23% [1]

Group 1 - The stock price of Dongfang Zhenxuan (1797.HK) experienced a significant increase of over 23% before sharply declining, with a further drop of 20% and a trading volume exceeding 8 billion HKD, resulting in a daily fluctuation of 43% [1] - In the past two months, Dongfang Zhenxuan's stock price surged, with an increase of 85% in July and an additional 144% in August, reaching a new high since February 2023 during intraday trading [3]

东方甄选(1797.HK)在拉升超23%后高台跳水，目前跌幅进一步扩大至20%，日内振幅达43%。 东方甄选最近两个月股价比飙升，在7月份累涨85%后，8月一度再累涨144%。今日盘中股价一度创 2023年2月以来新高。 本文源自：金融界 ...

东方甄选最近两个月股价飙升，在7月份累涨85%后，8月一度再累涨144%。今日盘中股价一度创2023 年2月以来新高。 格隆汇8月19日｜东方甄选(1797.HK)在拉升超23%后高台跳水，目前跌幅进一步扩大至20%，成交额放 大至逾80亿港元，日内振幅达43%。 ...

东方甄选尾盘跳水跌超18%，此前一度涨23%。 ...

（文章来源：每日经济新闻） 每经AI快讯，8月19日，东方甄选尾盘跳水跌20%，此前一度涨23%。 ...

(责任编辑：宋政 HN002) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 格隆汇8月19日｜东方甄选(1797.HK)短线跳水转跌，目前跌超8%，此前盘中涨幅达23%。 ...